At a glance
Dr. Lim Wee Chai of Top Glove Corporation
Reported an RM81 million Profit After Tax and a 1,675% operating profit surge to RM142 million
For the third quarter (Q3 FY2026) ended May 31, 2026
Global healthcare manufacturing industry sector, headquartered in Malaysia and ranked in S&P Dow Jones Best in Class
Operating margins rebounded due to rigorous internal cost-containment measures and robust global consumer demand for essential glove products
Achieved by increasing average selling prices to pass on latex costs and flexibly switching production lines to prevent disruptions
Resilient Growth and Strategic Agility
Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the global manufacturing sector.
The following analysis distills the most critical financial and operational signals from these results. It clarifies how the company navigated severe supply chain disruptions to deliver triple-digit bottom-line expansion for its shareholders.
The 138% Profit Surge
The Group reported a Profit After Tax of RM81 million for Q3 FY2026, a significant jump from the RM34 million recorded in the same period last year. Revenue for the quarter rose by 32% to RM1.1 billion, contributing to a nine-month total of approximately RM3.0 billion.
While the bottom-line growth is impressive, the real story lies in the staggering 1,675% surge in operating profit to RM142 million. This outsized growth relative to revenue signals a high degree of operating leverage and the success of rigorous cost-containment measures.
Strategic Supply Chain Agility
The company navigated recent nitrile latex supply disruptions by implementing a counter-intuitive sourcing strategy. While competitors might scale back production to manage costs during such disruptions, Top Glove leveraged its diversified supplier network to ensure uninterrupted manufacturing and capture market share.
This resilience is bolstered by flexible manufacturing capabilities that allow production lines to switch between nitrile and natural rubber gloves based on material availability. With a total capacity of 95 billion pieces per annum, this agility serves as a vital hedge against raw material price volatility.
Executive Chairman Tan Sri Dr Lim Wee Chai attributed this success to the team’s internal coordination and external partnerships.
“Our steady performance was attributed to sustained efforts to strengthen our operational fundamentals. Proactive sourcing efforts have ensured uninterrupted glove production and deliveries, while improvement initiatives in quality and cost management positioned us to remain resilient.”
Pricing Power in Action
Top Glove demonstrated significant pricing power during the quarter by implementing timely average selling price adjustments. These hikes allowed the Group to pass escalating raw material costs for both natural and nitrile latex directly to customers without losing momentum.
Evidence of this pricing discipline is found in the company’s volume metrics. Despite higher prices, sales volume for the nine-month period increased by 34%, proving that demand remains robust for the Group’s essential products.
Comparative Financial Snapshot
The following table summarizes the performance of Q3 FY2026 against the corresponding quarter in Q3 FY2025. These figures highlight the significant recovery in operating margins over the last twelve months.
| Financial Metric | Q3 FY2026 (RM’mil) | Q3 FY2025 (RM’mil) | Variance (%) |
| Revenue | 1,095 | 830 | 32% |
| Operating Profit | 142 | 8 | 1,675% |
| Profit After Tax | 81 | 34 | 138% |
Institutional Stability and ESG Leadership
Recent changes to the Board of Directors underscore a commitment to strong governance and succession planning. Datuk Dr Norma binti Mansor has retired and is succeeded by Mr. Lee Ah Too, who now serves as the Senior Independent Non-Executive Director.
The Board also appointed Ms. Liew Way Keng as a new Independent Non-Executive Director, maintaining female representation at 44%. This figure comfortably surpasses the 30% institutional benchmark for board diversity.
Further validating its institutional health, Top Glove maintained its inclusion in the S&P Dow Jones Best in Class Index 2026. This marks the seventh consecutive year the Group has been recognized for its leadership in sustainability within the healthcare equipment sector.
Looking Ahead
The Q3 FY2026 results reveal a company that has successfully transitioned from stabilization to resilient growth. Through disciplined pricing, manufacturing flexibility, and operational excellence, Top Glove has reinforced its position as a dominant force in the global market.
Related stories: What Top Glove’s Q2 FY2026 Comeback Reveals About Their Future